Total Payments
$89,133
2024 Payments
$5,117
Companies
72
Transactions
1,383
Medicare Patients
6,881
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$64,525 (72.4%)
Food & Beverage$20,439 (22.9%)
Travel$3,804 (4.3%)
Education$365.22 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64,525 | 45 | 72.4% |
| Food and Beverage | $20,439 | 1,308 | 22.9% |
| Travel and Lodging | $3,804 | 17 | 4.3% |
| Education | $365.22 | 13 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $47,627 | 310 | $0 (2024) |
| Allergan, Inc. | $23,055 | 138 | $0 (2021) |
| LivaNova USA, Inc. | $2,292 | 25 | $0 (2022) |
| Abbott Laboratories | $1,877 | 17 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $1,372 | 61 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $981.53 | 90 | $0 (2024) |
| PFIZER INC. | $887.69 | 77 | $0 (2024) |
| Lilly USA, LLC | $735.06 | 49 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $728.84 | 40 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $708.68 | 39 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,117 | 163 | ABBVIE INC. ($3,370) |
| 2023 | $11,713 | 217 | AbbVie Inc. ($9,417) |
| 2022 | $16,739 | 235 | ABBVIE INC. ($14,518) |
| 2021 | $26,805 | 242 | AbbVie Inc. ($20,322) |
| 2020 | $19,774 | 196 | Allergan, Inc. ($18,380) |
| 2019 | $3,315 | 135 | LivaNova USA, Inc. ($1,383) |
| 2018 | $3,312 | 106 | Abbott Laboratories ($1,857) |
| 2017 | $2,359 | 89 | LivaNova USA, Inc. ($464.95) |
All Payment Transactions
1,383 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Neurology | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/04/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: PAIN | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Neurology | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: PAIN | ||||||
| 11/18/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Pain Management | ||||||
| 11/14/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: PAIN | ||||||
| 10/31/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Pain Management | ||||||
| 10/29/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Neurology | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: PAIN | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: PAIN | ||||||
| 10/24/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Pain Management | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: PAIN | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Central Nervous System | ||||||
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 1,936 | 20,385 | $743,333 | $542,251 |
| 2022 | 32 | 2,015 | 22,760 | $610,822 | $461,505 |
| 2021 | 28 | 1,725 | 18,870 | $576,274 | $448,458 |
| 2020 | 29 | 1,205 | 17,404 | $890,416 | $310,892 |
Total Patients
6,881
Total Services
79,419
Medicare Billing
$1.8M
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2023 | 35 | 119 | $123,339 | $96,698 | 78.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 27 | 17,701 | $111,826 | $87,500 | 78.2% |
| 95707 | Measurement of brain wave activity (eeg), 2-12 hours with continuous monitoring | Office | 2023 | 90 | 90 | $48,506 | $38,030 | 78.4% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 97 | 148 | $38,350 | $29,313 | 76.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 75 | 296 | $33,421 | $26,202 | 78.4% |
| 64640 | Destruction of peripheral nerve or branch | Office | 2023 | 19 | 163 | $46,660 | $21,817 | 46.8% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 89 | 89 | $28,534 | $21,574 | 75.6% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Office | 2023 | 35 | 119 | $27,112 | $21,255 | 78.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 49 | 49 | $22,271 | $17,460 | 78.4% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 62 | 62 | $20,169 | $15,812 | 78.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 82 | 82 | $18,537 | $11,602 | 62.6% |
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours | Office | 2023 | 24 | 94 | $14,614 | $11,458 | 78.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 48 | 51 | $14,545 | $9,484 | 65.2% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 34 | 34 | $10,700 | $8,139 | 76.1% |
| 95717 | Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report | Office | 2023 | 90 | 90 | $9,989 | $7,831 | 78.4% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 85 | 85 | $12,906 | $7,638 | 59.2% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 51 | 51 | $19,263 | $7,634 | 39.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 18 | 58 | $10,073 | $7,489 | 74.3% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 65 | 65 | $9,335 | $7,206 | 77.2% |
| 93930 | Ultrasound of arm arteries or artery grafts | Office | 2023 | 45 | 48 | $11,118 | $6,846 | 61.6% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 59 | 59 | $8,402 | $6,446 | 76.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $8,352 | $6,389 | 76.5% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 25 | 25 | $8,022 | $6,289 | 78.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 41 | 56 | $7,971 | $5,689 | 71.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 50 | $7,148 | $5,604 | 78.4% |
About Dr. Lydia Shajenko, M.D
Dr. Lydia Shajenko, M.D is a Neurology healthcare provider based in Edgewater, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841289634.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lydia Shajenko, M.D has received a total of $89,133 in payments from pharmaceutical and medical device companies, with $5,117 received in 2024. These payments were reported across 1,383 transactions from 72 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($64,525).
As a Medicare-enrolled provider, Shajenko has provided services to 6,881 Medicare beneficiaries, totaling 79,419 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology
- Location Edgewater, NJ
- Active Since 10/14/2005
- Last Updated 10/26/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1841289634
Products in Payments
- UBRELVY (Drug) $43,806
- VRAYLAR (Drug) $14,050
- QULIPTA (Drug) $11,897
- VNS Therapy (Device) $2,242
- NURTEC ODT (Drug) $1,485
- Infinity DBS Pulse Generators (Device) $831.66
- Iovera (Device) $615.39
- Neuromodulation Dspsbls and Accs (Device) $582.82
- BOTOX (Biological) $582.42
- ZTLido (Drug) $568.57
- DUEXIS (Drug) $525.12
- NUEDEXTA (Drug) $487.98
- EMGALITY (Drug) $487.10
- Aimovig (Biological) $452.22
- VYEPTI (Biological) $447.99
- Neuromodulation Disposables and Accessories (Device) $442.10
- Movantik (Drug) $402.23
- AUSTEDO (Drug) $348.55
- Azstarys (Drug) $323.39
- APTIOM (Drug) $279.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.